Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:03.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the v3.4.1 notice about government funding was removed; these are administrative updates that do not affect core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T11:47:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting updates and changed the page revision to v3.4.1; the previous v3.4.0 entry was removed.
    Difference
    0.6%
    Check dated 2026-02-04T10:27:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes UI updates such as a glossary toggle and color-coded change highlights, plus an updated revision label. No substantive study data or core content were altered.
    Difference
    0.8%
    Check dated 2026-01-28T06:23:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Record History adds a new site revision entry, Revision v3.3.4, and removes Revision v3.3.3. This update is administrative and does not alter trial data or core page content.
    Difference
    0.1%
    Check dated 2026-01-14T02:50:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a revision note 'Revision: v3.3.3'. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T14:20:43.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.